ADC Therapeutics Cash Flow Statement (2019-2023) | ADCT

Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating Activities
Net Income -0.03M-0.03M-0.04M-43.28M-126.35M-20.33M-51.31M-72.09M-71.26M-0.08M-19.00M-66.27M-52.03M-0.02M-59.95M-48.20M-45.30M
Depreciation and Depletion 0.28M0.29M-0.38M0.42M0.40M2.11M0.31M0.30M0.29M0.16M0.26M0.27M0.32M0.34M
Share-based Compensation 216.001.12M3.79M0.01M0.02M0.01M60.43M0.01M0.01M0.01M49.28M8.07M1.12M2.08M2.22M
Deferred Taxes -0.00M-0.00M441.00-1.61M-0.07M-5.10M-0.58M42.85M
Gains from Sales and Divestitures 329.00531.00553.00
Gains from Investment Securities -53.00-0.01M-0.00M-11.49M-0.62M-0.02M-0.14M0.28M
Asset Writedowns and Impairment 767.002.16M0.05M0.73M0.83M
Cash from Operations -0.03M-122.35M-32.47M-0.06M-0.06M-0.06M-233.21M-0.03M-0.05M0.00M-138.23M-15.39M-34.99M-36.67M-31.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -33.000.13M-26.00-37.00-33.0012.20M0.86M4.49M6.71M7.16M
Amortization of Deferred Charges 0.83M0.67M0.82M0.69M
Depreciation & Amortization (CF) 0.28M0.29M-0.38M0.42M0.40M2.11M0.31M0.30M0.29M0.16M0.26M0.27M0.32M0.34M
Change in Working Capital
Change in Receivables -140.000.19M-0.00M-0.00M-0.01M-30.20M0.00M0.01M-0.00M42.75M-48.90M-0.19M-2.70M4.00M
Change in Inventory 7.00-3.02M-355.00-0.00M-0.00M9.66M0.35M2.05M3.48M-0.17M
Change in Account Payables 0.00M-3.42M5.28M0.01M0.00M-0.00M6.79M0.00M-0.00M-0.00M0.31M-3.66M2.98M-2.71M6.57M
Change in Accured Expenses -107.00921.000.24M5.34M-5.33M-286.000.01M16.24M-12.30M-3.29M-0.52M1.96M
Change in Taxes 268.000.58M0.10M107.00240.00145.004.57M0.00M0.00M-0.00M1.84M587.00605.00493.00
Other Working Capital Changes 0.00M-0.00M-0.00M-6.35M-0.00M0.00M-0.00M11.46M-0.64M-4.29M-1.31M13.63M
Investing Activities
Capital Expenditures 1.02M1.21M0.66M0.33M
Change in Intangibles -8.00-25.00-0.38M-0.00M-933.00-113.00-889.00-759.00-60.00-13.00-20.001.00
Cash from Investing Activities -47.00-2.25M-0.50M-657.00-0.00M-0.00M-6.67M-0.00M-689.00-254.00-0.68M-1.02M-1.21M-0.66M-0.33M
Financing Activities
Cash from Financing Activities -290.00100.41M-0.28M-297.000.05M0.22M267.13M-258.00-252.000.00M-0.90M0.42M73.10M0.35M-0.00M
Additional items
Exchange Rate Effect -64.000.06M-0.10M30.0015.00-68.000.01M-82.00-145.00-224.00-0.21M0.09M0.06M-0.12M0.15M
Change in Cash -15.98M36.90M-36.98M-31.96M
Beginning Cash Balance 182.16M0.15M115.55M0.12M0.35M0.49M0.44M0.44M0.53M466.54M0.47M466.54M466.54M326.44M342.42M310.61M347.39M31.96M
Free Cash Flow -0.03M-122.35M-32.47M-0.06M-0.06M-0.06M-233.21M-0.03M-0.05M0.00M-138.23M-16.41M-36.20M-37.33M-31.96M
Net Cash Flow -0.03M-24.18M-33.24M-0.06M-0.01M0.16M27.25M-0.04M-0.05M0.00M-139.81M-15.98M36.90M-36.98M-31.96M